Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine.
about
Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutationsAntiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv miceIn vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection.Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine.Critical design features of phenyl carboxylate-containing polymer microbicides.Absolute bioavailability and disposition of (-) and (+) 2'-deoxy- 3'-oxa-4'-thiocytidine (dOTC) following single intravenous and oral doses of racemic dOTC in humans.Safety, tolerability, and pharmacokinetics of single oral doses of BCH-10652 in healthy adult males.In vitro interactions between apricitabine and other deoxycytidine analoguesEffect of Lamivudine on the plasma and intracellular pharmacokinetics of apricitabine, a novel nucleoside reverse transcriptase inhibitor, in healthy volunteers.
P2860
Q28235418-8D44271E-70F9-43C0-895C-3AB0D437924FQ28343930-F986149E-CAAF-4CC0-8CA4-06C02A3EE1C2Q34352006-06FF29B5-22BD-4D24-9802-160CE4778C6FQ36295410-4A57B407-5417-471F-8836-800E1552E87BQ39383159-E40FE316-D187-4893-8BCB-00E0841DEABCQ39474118-2D4FF587-B5FB-4FA3-8FA4-C74E3B4A1378Q39475388-B71369C7-0984-4CAC-9607-F9BE04B53B55Q42041046-B414CB4A-EF65-49BD-A59B-E17D84CB7C6CQ42114337-28336391-3435-4C20-AF68-C2BC9C1417C4
P2860
Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2'-deoxy-3'-oxa-4'-thiocytidine.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Anti-human immunodeficiency vi ...... -deoxy-3'-oxa-4'-thiocytidine.
@ast
Anti-human immunodeficiency vi ...... -deoxy-3'-oxa-4'-thiocytidine.
@en
type
label
Anti-human immunodeficiency vi ...... -deoxy-3'-oxa-4'-thiocytidine.
@ast
Anti-human immunodeficiency vi ...... -deoxy-3'-oxa-4'-thiocytidine.
@en
prefLabel
Anti-human immunodeficiency vi ...... -deoxy-3'-oxa-4'-thiocytidine.
@ast
Anti-human immunodeficiency vi ...... -deoxy-3'-oxa-4'-thiocytidine.
@en
P2093
P2860
P1476
Anti-human immunodeficiency vi ...... '-deoxy-3'-oxa-4'-thiocytidine
@en
P2093
D L Taylor
H Gourdeau
J M de Muys
M A Wainberg
N Nguyen-Ba
P2860
P304
P407
P577
1999-08-01T00:00:00Z